Cardinal Health Stock Fundamentals

CAH Stock  USD 121.84  1.58  1.28%   
Cardinal Health fundamentals help investors to digest information that contributes to Cardinal Health's financial success or failures. It also enables traders to predict the movement of Cardinal Stock. The fundamental analysis module provides a way to measure Cardinal Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardinal Health stock.
As of now, Cardinal Health's Operating Income is increasing as compared to previous years. The Cardinal Health's current EBIT is estimated to increase to about 1.3 B, while Depreciation And Amortization is projected to decrease to under 360.6 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cardinal Health Company Current Valuation Analysis

Cardinal Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Cardinal Health Current Valuation

    
  31.78 B  
Most of Cardinal Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardinal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Cardinal Current Valuation Historical Pattern

Today, most investors in Cardinal Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cardinal Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cardinal Health current valuation as a starting point in their analysis.
   Cardinal Health Current Valuation   
       Timeline  
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Cardinal Health has a Current Valuation of 31.78 B. This is 121.28% higher than that of the Health Care Providers & Services sector and 139.9% higher than that of the Health Care industry. The current valuation for all United States stocks is 91.19% lower than that of the firm.

Cardinal Health Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cardinal Health's current stock value. Our valuation model uses many indicators to compare Cardinal Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardinal Health competition to find correlations between indicators driving Cardinal Health's intrinsic value. More Info.
Cardinal Health is rated third in return on asset category among its peers. It also is rated third in profit margin category among its peers fabricating about  0.18  of Profit Margin per Return On Asset. The ratio of Return On Asset to Profit Margin for Cardinal Health is roughly  5.58 . As of now, Cardinal Health's Net Profit Margin is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cardinal Health's earnings, one of the primary drivers of an investment's value.

Cardinal Health's Earnings Breakdown by Geography

Cardinal Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardinal Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardinal Health could also be used in its relative valuation, which is a method of valuing Cardinal Health by comparing valuation metrics of similar companies.
Cardinal Health is currently under evaluation in current valuation category among its peers.

Cardinal Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cardinal Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cardinal Health's managers, analysts, and investors.
Environmental
Governance
Social

Cardinal Fundamentals

About Cardinal Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cardinal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardinal Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardinal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.5 B2.4 B
Total Revenue226.8 B238.2 B
Cost Of Revenue219.4 B230.4 B
Sales General And Administrative To Revenue 0.04  0.04 
Revenue Per Share 925.82  24.58 
Ebit Per Revenue 0.01  0.03 

Currently Active Assets on Macroaxis

When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:
Check out Cardinal Health Piotroski F Score and Cardinal Health Altman Z Score analysis.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
48.135
Dividend Share
2.012
Earnings Share
5.2
Revenue Per Share
921.782
Quarterly Revenue Growth
(0.04)
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.